Get started
DDD

DEVYSER DIAGNOSTICS AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

DVYSR chart


Full chart

DVYSR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.29 B‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.5 SEK
Net income (FY)
‪−53.60 M‬ SEK
Revenue (FY)
‪169.30 M‬ SEK
Shares float
‪9.26 M‬
Beta (1Y)
0.63

Employees


Employees (FY)
118
Change (1Y)
+26 +28.26%
Revenue / Employee (1Y)
‪141.61 K‬ SEK
Net income / Employee (1Y)
‪−44.83 K‬ SEK

About DEVYSER DIAGNOSTICS AB


Sector
Health Technology
Industry
Medical Specialties
CEO
Fredrik Alpsten
Website
devyser.com
Headquarters
Hägersten
Founded
2004
ISIN
SE0016588867
FIGI
BBG013X97TG8
Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. Its products are used for complex DNA testing in the areas of hereditary diseases, oncology and post-transplantation monitoring. The firm's products are also used in treating cancer patients and in follow-up transplant patients. The company was founded by Anders Hedrum, Ulf Axel Klangby and Dan Hauzenberger in 2004 and is headquartered in Hägersten, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

DVYSR news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DVYSR is 138.0 SEK — it has decreased by −0.72% in the past 24 hours. Watch DEVYSER DIAGNOSTICS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange DEVYSER DIAGNOSTICS AB stocks are traded under the ticker DVYSR.
DVYSR stock has risen by 2.22% compared to the previous week, the month change is a 3.76% rise, over the last year DEVYSER DIAGNOSTICS AB has showed a 119.05% increase.
We've gathered analysts' opinions on DEVYSER DIAGNOSTICS AB future price: according to them, DVYSR price has a max estimate of 192.00 SEK and a min estimate of 135.00 SEK. Watch DVYSR chart and read a more detailed DEVYSER DIAGNOSTICS AB stock forecast: see what analysts think of DEVYSER DIAGNOSTICS AB and suggest that you do with its stocks.
DVYSR reached its all-time high on Nov 1, 2024 with the price of 139.0 SEK, and its all-time low was 56.0 SEK and was reached on Apr 27, 2022. View more price dynamics on DVYSR chart.
See other stocks reaching their highest and lowest prices.
DVYSR stock is 2.17% volatile and has beta coefficient of 0.63. Track DEVYSER DIAGNOSTICS AB stock price on the chart and check out the list of the most volatile stocks — is DEVYSER DIAGNOSTICS AB there?
Yes, you can track DEVYSER DIAGNOSTICS AB financials in yearly and quarterly reports right on TradingView.
DEVYSER DIAGNOSTICS AB is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
DVYSR earnings for the last quarter are −1.40 SEK per share, whereas the estimation was −1.07 SEK resulting in a −30.58% surprise. The estimated earnings for the next quarter are −0.68 SEK per share. See more details about DEVYSER DIAGNOSTICS AB earnings.
DEVYSER DIAGNOSTICS AB revenue for the last quarter amounts to ‪48.70 M‬ SEK, despite the estimated figure of ‪55.22 M‬ SEK. In the next quarter, revenue is expected to reach ‪63.88 M‬ SEK.
DVYSR net income for the last quarter is ‪−23.20 M‬ SEK, while the quarter before that showed ‪−22.90 M‬ SEK of net income which accounts for −1.31% change. Track more DEVYSER DIAGNOSTICS AB financial stats to get the full picture.
No, DVYSR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 118.00 employees. See our rating of the largest employees — is DEVYSER DIAGNOSTICS AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DEVYSER DIAGNOSTICS AB EBITDA is ‪−53.90 M‬ SEK, and current EBITDA margin is −27.58%. See more stats in DEVYSER DIAGNOSTICS AB financial statements.
Like other stocks, DVYSR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DEVYSER DIAGNOSTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DEVYSER DIAGNOSTICS AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DEVYSER DIAGNOSTICS AB stock shows the buy signal. See more of DEVYSER DIAGNOSTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.